What Happened?
Wayne, AB-based NFlection-Therapeutics Appointed Christopher Powala as President and Chief Executive Officer
About the Company
NFlection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi and nevus sebaceous.
About the Person
Christopher Powala is President and Chief Executive Officer at NFlection Therapeutics. Previously, Christopher held various senior HR leadership roles in the industry.
Info Source
News
Short Profile